• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产酸克雷伯菌临床分离株中的氟喹诺酮耐药性

Fluoroquinolone resistance in clinical isolates of Klebsiella oxytoca.

作者信息

Horii Toshinobu, Osaki Mai, Muramatsu Hideaki

机构信息

Division of Bacteriology, Department of Microbiology and Immunology, Tottori University Faculty of Medicine, Yonago, Japan.

出版信息

Chemotherapy. 2008;54(4):323-7. doi: 10.1159/000151266. Epub 2007 Jul 30.

DOI:10.1159/000151266
PMID:18698136
Abstract

BACKGROUND

Prevalence of fluoroquinolone-resistant Klebsiella oxytoca has been reported worldwide.

METHODS

We recovered ten clinical K. oxytoca isolates from patients with acute cystitis, asymptomatic bacteriuria or acute bacillary diarrhea in Japan. Out of ten isolates, one fluoroquinolone-susceptible isolate was included as a control. Fluoroquinolone resistance was characterized genetically by PCR and DNA sequencing methods. Outer membrane protein (OMP) profiles were determined by SDS-PAGE.

RESULTS

In nine clinical isolates of levofloxacin-resistant K. oxytoca, nucleotide sequences in the quinolone-resistance-determining regions showed amino acid mutations such as Thr83Ile and Asp87Gly in GyrA and Ser80Ile in ParC. Combined effects of reduced 36-kDa OMP production and amino acid mutations in GyrA and ParC were shown by two K. oxytoca isolates exhibiting higher minimum inhibitory concentrations for fluoroquinolones than other fluoroquinolone-resistant isolates.

CONCLUSIONS

In clinical K. oxytoca isolates, the various mechanisms of fluoroquinolone resistance may include reduced 36-kDa OMP production as well as GyrA and ParC mutations.

摘要

背景

耐氟喹诺酮类产酸克雷伯菌的流行情况已在全球范围内报道。

方法

我们从日本急性膀胱炎、无症状菌尿症或急性细菌性腹泻患者中分离出10株临床产酸克雷伯菌。在这10株分离菌中,纳入1株对氟喹诺酮敏感的分离菌作为对照。采用聚合酶链反应(PCR)和DNA测序方法对氟喹诺酮耐药性进行基因特征分析。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)测定外膜蛋白(OMP)谱。

结果

在9株耐左氧氟沙星产酸克雷伯菌临床分离株中,喹诺酮耐药决定区的核苷酸序列显示出氨基酸突变,如GyrA中的Thr83Ile和Asp87Gly以及ParC中的Ser80Ile。两株产酸克雷伯菌分离株对氟喹诺酮的最低抑菌浓度高于其他耐氟喹诺酮分离株,显示出36-kDa OMP产生减少以及GyrA和ParC氨基酸突变的联合作用。

结论

在临床产酸克雷伯菌分离株中,氟喹诺酮耐药的多种机制可能包括36-kDa OMP产生减少以及GyrA和ParC突变。

相似文献

1
Fluoroquinolone resistance in clinical isolates of Klebsiella oxytoca.产酸克雷伯菌临床分离株中的氟喹诺酮耐药性
Chemotherapy. 2008;54(4):323-7. doi: 10.1159/000151266. Epub 2007 Jul 30.
2
Mechanisms of resistance to fluoroquinolones and carbapenems in Pseudomonas putida.恶臭假单胞菌对氟喹诺酮类和碳青霉烯类抗生素的耐药机制
J Antimicrob Chemother. 2005 Oct;56(4):643-7. doi: 10.1093/jac/dki254. Epub 2005 Jul 26.
3
In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.司帕沙星对肺炎链球菌临床菌株的体外活性,这些菌株在gyrase A和拓扑异构酶IV的喹诺酮耐药决定区(QRDRs)中有特定的氨基酸替代。
J Antimicrob Chemother. 2006 Dec;58(6):1279-82. doi: 10.1093/jac/dkl427. Epub 2006 Oct 20.
4
Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.全球耐氟喹诺酮肺炎链球菌的发病率、分子流行病学及相关突变:来自全球PROTEKT监测项目的数据
J Antimicrob Chemother. 2003 Dec;52(6):944-52. doi: 10.1093/jac/dkg465. Epub 2003 Oct 29.
5
Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.化脓性链球菌emm6型中高水平氟喹诺酮耐药性的出现以及环丙沙星、左氧氟沙星和莫西沙星的体外耐药性选择。
J Antimicrob Chemother. 2009 May;63(5):886-94. doi: 10.1093/jac/dkp057. Epub 2009 Mar 11.
6
Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.从鸡中分离的大肠杆菌的氟喹诺酮耐药性及gyrA和parC基因突变
J Microbiol. 2005 Oct;43(5):391-7.
7
Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.肺炎链球菌对氟喹诺酮敏感的分离株真的敏感吗?1997年和2003年加拿大分离株耐药机制的比较。
J Antimicrob Chemother. 2005 Oct;56(4):769-72. doi: 10.1093/jac/dki315. Epub 2005 Aug 26.
8
Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.II型拓扑异构酶突变和AcrAB外排泵在奇异变形杆菌耐氟喹诺酮临床分离株中的作用
J Antimicrob Chemother. 2006 Sep;58(3):673-7. doi: 10.1093/jac/dkl297. Epub 2006 Jul 26.
9
Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.泌尿道病原体中氟喹诺酮耐药机制的分析。
J Antimicrob Chemother. 2006 Dec;58(6):1274-8. doi: 10.1093/jac/dkl404. Epub 2006 Oct 13.
10
Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.禽源沙门氏菌血清型对氟喹诺酮类药物敏感性降低的分子机制及其在突变预防浓度测定过程中筛选出的突变体
J Antimicrob Chemother. 2007 May;59(5):886-92. doi: 10.1093/jac/dkm072. Epub 2007 Mar 16.

引用本文的文献

1
Phylogenetic lineages and antimicrobial resistance determinants of clinical spanning local to global scales.跨越地方到全球范围的临床菌株的系统发育谱系和抗菌药物耐药性决定因素。
Microbiol Spectr. 2023 Sep 7;11(5):e0054923. doi: 10.1128/spectrum.00549-23.
2
Epidemiology, Environmental Risks, Virulence, and Resistance Determinants of From Dairy Cows in Hubei, China.中国湖北奶牛的流行病学、环境风险、毒力及耐药性决定因素
Front Microbiol. 2022 May 4;13:858799. doi: 10.3389/fmicb.2022.858799. eCollection 2022.
3
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence.
产酸克雷伯菌复合体:分类学、抗菌耐药性和毒力的最新研究进展。
Clin Microbiol Rev. 2022 Jan 19;35(1):e0000621. doi: 10.1128/CMR.00006-21. Epub 2021 Dec 1.